(Q46648044)

30 June 2019

title

Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy (English)

1 reference

30 June 2019

author

Georg Ramm

6

1 reference

PubMed publication ID

26508318

23 December 2017

http://europepmc.org/abstract/MED/26508318

author name string

Jay C Jha

1

1 reference

30 June 2019

Vicki Thallas-Bonke

2

1 reference

30 June 2019

Claudine Banal

3

1 reference

30 June 2019

Stephen P Gray

4

1 reference

30 June 2019

Bryna S M Chow

5

1 reference

30 June 2019

Susan E Quaggin

7

1 reference

30 June 2019

Mark E Cooper

8

1 reference

30 June 2019

Harald H H W Schmidt

9

1 reference

30 June 2019

Karin A Jandeleit-Dahm

10

1 reference

30 June 2019

publication date

28 October 2015

1 reference

30 June 2019

published in

Diabetologia

1 reference

30 June 2019

volume

59

1 reference

30 June 2019

issue

2

1 reference

30 June 2019

page(s)

379-389

1 reference

30 June 2019

https://scigraph.springernature.com/pub.10.1007/s00125-015-3796-0

exact match

0 references

cites work

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Hereditary proteinuria syndromes and mechanisms of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

NADPH oxidases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Involvement of oxidative stress in the pathogenesis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Angiotensin II induces apoptosis in rat glomerular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Apoptosis in podocytes induced by TGF-beta and Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Effects of NADPH oxidase inhibitor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Genetic deletion of cell division autoantigen 1 retards diabetes-associated renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Validation of glomerular basement membrane thickness changes with aging in minimal change disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Role of nephrin in renal disease including diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Pathologic classification of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Isolate diffuse thickening of glomerular capillary basement membrane: a renal lesion in prediabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Redox control of protein kinase C: cell- and disease-specific aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3796-0

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice

21 January 2018

1 reference

12 December 2020

Glomerular epithelial foot processes and filtration slits in IDDM patients

1 reference

12 December 2020

Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy

1 reference

12 December 2020

F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes

1 reference

12 December 2020

Polyantigenic expansion of basement membrane constituents in diabetic nephropathy

1 reference

12 December 2020

Nephropathy in diabetes

1 reference

12 December 2020

The burden of mortality attributable to diabetes: realistic estimates for the year 2000

1 reference

12 December 2020

Differential expression of basement membrane collagen chains in diabetic nephropathy

1 reference

12 December 2020

Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin

1 reference

12 December 2020

A noninvasive computerized tail-cuff system for measuring blood pressure in mice

1 reference

12 December 2020

Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy

1 reference

12 December 2020

Molecular Basis of Proteinuria of Glomerular Origin

1 reference

12 December 2020

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

1 reference

12 December 2020

10.1007/S00125-015-3796-0

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6450410

1 reference

30 June 2019

PubMed publication ID

26508318

1 reference

30 June 2019